VCAM1 and lung cancer: We confirmed that this antibody specifically inhibited the invasion of A549 and NCI-H1299 lung cancer cell lines, suggesting that VCAM-1-D6 may be a novel potential therapeutic target in VCAM-1-mediated lung cancer invasion.